Ethinyl Estradiol Information

What's inside Ethinyl Estradiol

Ethinyl Estradiol in the News

Barr wins key ruling in Yasmin patent dispute - Trading Markets (press release)
Yasmin (drospirenone and ethinyl estradiol) provides an oral contraceptive regimen consisting of 21 active tablets each containing 3mg of drospirenone and ...
Tue Mar 04 06:55:48 -0500 2008

Watson Files Application for Generic SEASONIQUE(R) - PR Newswire (press release)
... Inc., a subsidiary of Barr Pharmaceuticals, Inc. Watson's levonorgestrel and ethinyl estradiol product is a generic version of Barr's SEASONIQUE(R). ...
Tue Mar 04 16:10:02 -0500 2008

Watson files application for generic contraceptive drug - Trading Markets (press release)
Watson's levonorgestrel and ethinyl estradiol product is a generic version of Barr's Seasonique. On January 23, 2008, Watson has notified Barr that it had ...
Wed Mar 05 05:16:17 -0500 2008

Ethinyl Estradiol Chemical Information

ethinyl estradiol - A semisynthetic estrogen. Ethinyl estradiol binds to the estrogen receptor complex and enters the nucleus, activating DNA transcription of genes involved in estrogenic cellular responses. This agent also inhibits 5-alpha reductase in epididymal tissue, which lowers testosterone levels and may delay progression of prostatic cancer. In addition to its antineoplastic effects, ethinyl estradiol protects against osteoporosis. In animal models, short-term therapy with this agent has been shown to provide long-term protection against breast cancer, mimicking the antitumor effects of pregnancy. (NCI04)